Skip to main content

Table 7 Correlation between PFS and clinical-pathological data in a multivariate analysis

From: Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study

 

HR

95%CI

p

Age

  < 50

   

  ≥ 50

1.4

0.84–2.3

0.2

VD level

  < 20 ng/mL

   

  ≥ 20 ng/mL

0.9

0.6–1.5

0.8

Clinical stage

 I-II

   

 III

2.4

1.4–3.9

0.001

Tumor subtypes

 HER2+

1.6

0.30–1.21

0.2

 HR+/HER2-

   

 TNBC

4.3

1.42–4.80

0.002

pCR

 no

   

 yes

0.25

0.12–0.50

0.0001

SBR grade

 II

   

 III

0.94

0.52–1.70

0.8